1Q22 Investor Update

Q1 2022 BUSINESS HIGHLIGHTS Improving efficiencies and scaling across national portfolio 1 X Performance Highlights Generated Revenue of $123 million, 46% Gross Margin and Adjusted EBITDA(1) of $17 million 1) Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP figures 2 3 4 5 Nearly 700bps of Gross Margin improvement over the prior year, indicative of improved cultivation and greater proportion of in-house brands of retail sales Adjusted EBITDA Margin(¹) increased 931bps over the prior year, as markets such as Maryland, New Jersey and Virginia ramp and add to the bottom line Added 5 new retail locations, including four in West Virginia and an additional location in Virginia; converted Brooklyn, NY retail location to Cannabist Cultivation productivity continues improving with focus on potency and productivity (useable flower g/sqft) and standardized SOPs across platform Improvement of retail share of internal brand sales; Columbia Care flower brands now represent 70% of sales in own dispensaries 7 Columbia Care

View entire presentation